Analytical Data
-
基因名
catD
- Application
-
别名
(CAT)
-
种属
Clostridioides difficile
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P11504
-
表达区间
1-212aa
-
分子量
32.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CatD, or Cathepsin D, is a lysosomal aspartic protease that plays a crucial role in protein degradation and processing within cells. It is involved in various physiological processes, including autophagy, antigen presentation, and tissue remodeling, making it a significant player in both health and disease. Dysregulation of CatD has been linked to several pathological conditions, such as cancer, neurodegenerative diseases, and inflammatory disorders. Research on CatD recombinant proteins has gained considerable attention due to their potential applications in therapeutic and diagnostic settings. Recombinant expression techniques enable the production of active CatD for studying its structure-function relationships, enzymatic activity, and interaction with other cellular components. Understanding CatD's specific biological roles can lead to the development of targeted therapies and novel biomarkers for diseases associated with its dysfunction. Furthermore, studying CatD in various models can provide insights into its involvement in disease progression and response to treatment. Overall, the exploration of CatD recombinant proteins holds promise for advancing our knowledge of its biology and translating this knowledge into clinical applications.
